Evidence map›Paper›PMID 39109582›Full record

ArticleClinical oral implants research2024

Alveolar bone regeneration using a 3D-printed patient-specific resorbable scaffold for dental implant placement: A case report.

Sašo Ivanovski, Reuben Staples, Himanshu Arora, Cedryck Vaquette, Jamil Alayan

Registry-linked trialAbstract readCase Reports
In one paragraph

Article in Clinical oral implants research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06773923 (Effectiveness of Patient-specific 3D-printed Resorbable Scaffolds of Polycaprolactone, Beta-tricalcium Phosphate, and Metformin Used for Maxillary Bone Regeneration), which is not on this map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06773923 phase3enrolling by invitationnot on this map

Effectiveness of Patient-specific 3D-printed Resorbable Scaffolds of Polycaprolactone, Beta-tricalcium Phosphate, and Metformin Used for Maxillary Bone Regeneration: Randomized Clinical Trial

TypeinterventionalSponsorUniversidad Austral de ChileRan2024 to 2025Enrolled10ConditionsBone Loss, Jaw, Edentulous, Edentulous Mouth, Jaw FracturesArmsPCL Scaffold, PTFE + Bio-Oss®
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sašo IvanovskiThe University of Queensland, School of Dentistry, Herston, Queensland, Australia.ORCID 0000-0001-5339-0936
Reuben StaplesThe University of Queensland, School of Dentistry, Herston, Queensland, Australia.
Himanshu AroraThe University of Queensland, School of Dentistry, Herston, Queensland, Australia.ORCID 0000-0002-7181-0006
Cedryck VaquetteThe University of Queensland, School of Dentistry, Herston, Queensland, Australia.
Jamil AlayanThe University of Queensland, School of Dentistry, Herston, Queensland, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis case report demonstrates the effective clinical application of a 3D-printed, patient-specific polycaprolactone (PCL) resorbable scaffold for staged alveolar bone augmentation.

objectiveTo evaluate the effectiveness of a 3D-printed PCL scaffold in facilitating alveolar bone regeneration and subsequent dental implant placement. MATERIALS AND

methodsA 46-year-old man with a missing tooth (11) underwent staged alveolar bone augmentation using a patient-specific PCL scaffold. Volumetric bone gain and implant stability were assessed. Histological analysis was conducted to evaluate new bone formation and graft integration.

resultsThe novel approach resulted in a volumetric bone gain of 364.69 ± 2.53 mm

conclusionsThis proof-of-concept underscores the potential of 3D-printed scaffolds in personalized dental reconstruction and alveolar bone regeneration. It marks a significant step forward in integrating additive manufacturing technologies into clinical practice through a scaffold-guided bone regeneration (SGBR) approach. The trial was registered with the Australian New Zealand Clinical Trials Registry (ACTRN12622000118707p).

Indexed as

Alveolar Ridge AugmentationBone RegenerationPrinting, Three-DimensionalTissue ScaffoldsAbsorbable ImplantsDental Implantation, EndosseousDental ImplantsHumansMaleMiddle AgedPolyestersDental ImplantspolycaprolactonePolyesters3D printingcase reportguided bone regenerationPolycaprolactonescaffold‐guided bone regeneration

Identifiers

PMID39109582
PMCPMC11629455

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.